PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B

Protein phosphatase-2A (PP2A), an important phosphatase in dephosphoiylating tau and preserving synapse, is significantly suppressed in Alzheimer's disease (AD), but the mechanism is not well understood. Here, we studied whether phosphotyrosyl phosphatase activator (PTPA) could activate PP2A by reducing its inhibitory phosphorylation at tyrosine 307 (P-PP2A(c)). We found that overexpression of PTPA activated PP2A by decreasing the level of P-PP2A(c) with reduced phosphorylation of tau, while knockdown of PTPA inhibited PP2A by increasing the level of P-PP2A(c) with enhanced tau phosphorylation. We also observed that expression of PTPA could upregulate the protein and mRNA levels of protein tyrosine phosphatase 1B (PTPIB) and simultaneous downregulation of PTPIB eliminated PTPA-induced PP2A activation. Importantly, we also found that the protein level of PTPA is downregulated in the brains of AD patients, and the AD transgenic mouse models with expression of mutant human amyloid precursor protein (hAPP) or the longest human tau (htau), respectively. Our data indicate that PTPA may activate PP2A through activating PTP1B and thus reducing the level of P-PP2A(c), therefore upregulation of PTPA may represent a potential strategy in rescuing PP2A and arresting tau pathology in AD. (C) 2013 Elsevier B.V. All rights reserved.